Klaviyo Co-CEO Unloads Million: Is It a Sell Signal?
Two substantial share sales by Klaviyo's co-CEO in February and March sparked questions about whether this is a warni...
Compare daily and long-term volatility across major coins to inform allocation and risk controls in your portfolio.
20,930 articlesTwo substantial share sales by Klaviyo's co-CEO in February and March sparked questions about whether this is a warni...
If you want a backbone for a long-term portfolio, consumer staples stocks can deliver. This guide highlights three en...
Experts debate if real estate finally “bottomed,” signaling a potential shift in loans and pricing. This guide breaks...
Two rising names—Oklo and Centrus Energy—are shaping the future of U.S. nuclear energy. This guide breaks down which ...
This in-depth look breaks down SAIC's saic (saic) 2026 earnings landscape, weighing revenue drivers, margins, and ris...
Dividend investing can deliver steady income even when markets swing. Here are three no-brainer dividend stocks right...
Joe Kent, a former Army Special Forces officer and two-time congressional candidate, quit today from a top counterter...
The U.S.-led airstrike on Iran sent markets into a tailspin, with oil surging and stock indexes dropping. As policyma...
A major institutional move is reshaping exposure to European financials. Learn how 1607 Capital Partners builds a sta...
Analysts project a multi-year path for novo nordisk (nvo) stock, supported by strong product momentum but tempered by...
As March 27 nears, travel and markets face a critical test: TSA delays mount and a partial shutdown looms, threatenin...
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...